IS:JUBILANT Jubilant Life Sciences Limited

Jubilant Life Sciences Limited manufactures and supplies active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products, advance intermediates, fine ingredients, crop science ingredients, life science chemicals, and nutritional products. It offers APIs in the therapeutic areas of cardiovascular system, central nervous system, and anti-allergy streams; and develops multiple dosage forms, including oral solid, injectable, and ophthalmic dosage forms. The company also engages in the contract manufacturing of sterile injectables, ointment, creams and liquids, allergy therapy products, and radiopharmaceutical products; manufacture and market of radiopharmaceuticals for the diagnosis, treatment, and monitoring of various diseases; business of licensing generic dosage forms and providing regulatory services to generic pharmaceutical companies; and supply of generic dosage forms and bulk chemicals, such as ethyl acetate, acetic anhydride, etc., as well as vitamins to the European markets. In addition, it offers drug discovery services to pharmaceutical and biotech companies; clinical research data management services; channel screening services; and services in synthetic organic chemistry, combinatorial chemistry, medicinal chemistry, process research and development and manufacturing, scale up services, and GMP manufacturing-clinical supply to drug discovery companies of the United States, Europe, and internationally. Further, the company sells and distributes APIs in North America; and trades in advance intermediates, specialty ingredients, and nutrition products to pharmaceutical, animal feed and agrochemical industries in China. The company was formerly known as Jubilant Organosys Limited and changed its name to Jubilant Life Sciences Limited in 2010. The company was incorporated in 1978 and is based in Noida, India.

903.60 INR
As of 02/11/2021

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  07/01/2002
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   144,881,106,944 INR
Current dividend yield:   1.34%
Sedol:      B10SSN9

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy